Lataa...
Sitagliptin ameliorates the progression of atherosclerosis via down regulation of the inflammatory and oxidative pathways
BACK GROUND: Atherosclerosis is the major cause of death. The most common risk factors are hyperlipidemia, diabetes, and other factors like chronic infection and inflammation. OBJECTIVE: This study was undertaken to assess the effect of sitagliptin on atherosclerosis via interfering with inflammator...
Tallennettuna:
| Julkaisussa: | SAGE Open Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687767/ https://ncbi.nlm.nih.gov/pubmed/26770677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312113499912 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|